Literature DB >> 22609186

Depletion of protein kinase N3 (PKN3) impairs actin and adherens junctions dynamics and attenuates endothelial cell activation.

Kristin Möpert1, Kathrin Löffler, Nadine Röder, Jörg Kaufmann, Ansgar Santel.   

Abstract

Several pathways are involved in the control of endothelial cell morphology, endothelial permeability and function in order to maintain vascular homeostasis. Here we report that protein kinase N3 (PKN3) appears to play a pivotal role in maintaining endothelial cell morphology, cell-cell junctions and motility. An RNAi-based cell biological approach in cultured human endothelial cells (HUVEC) revealed that knockdown of PKN3 expression gave rise to cells with divergent cell morphology, impaired locomotion, disturbed adherens junctions (AJ) integrity and irregular actin organization. Notably, knockdown of PKN3 cells led to improper stress fiber formation and marked adhesiveness of intercellular adherens junctions when cells became stimulated with the pro-inflammatory cytokine TNF-α. Moreover, TNF-α-induced ICAM-1 expression on the cell surface was reduced in cells with suppressed PKN3 expression. Finally, loss-of-function for PKN3 appeared to affect Pyk2 phosphorylation in endothelial cells. These observations suggest that PKN3 can be considered a novel protein implicated in remodeling the actin-adherens junction, possibly by linking ICAM-1-signaling with actin/AJ dynamics. We propose that loss of PKN3 function and concomitant aberrations in actin rearrangement may attenuate pro-inflammatory activation of endothelial cells.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609186     DOI: 10.1016/j.ejcb.2012.03.010

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

1.  A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification.

Authors:  Christopher M Browne; Baishan Jiang; Scott B Ficarro; Zainab M Doctor; Jared L Johnson; Joseph D Card; Sindhu Carmen Sivakumaren; William M Alexander; Tomer M Yaron; Charles J Murphy; Nicholas P Kwiatkowski; Tinghu Zhang; Lewis C Cantley; Nathanael S Gray; Jarrod A Marto
Journal:  J Am Chem Soc       Date:  2018-12-20       Impact factor: 15.419

2.  Exploration of molecular pathways mediating electric field-directed Schwann cell migration by RNA-seq.

Authors:  Li Yao; Yongchao Li; Jennifer Knapp; Peter Smith
Journal:  J Cell Physiol       Date:  2015-07       Impact factor: 6.384

Review 3.  Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.

Authors:  Lígia Catarina Gomes-da-Silva; Sérgio Simões; João Nuno Moreira
Journal:  Cell Mol Life Sci       Date:  2013-11-13       Impact factor: 9.261

4.  Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.

Authors:  Matthew D Falk; Wei Liu; Ben Bolaños; Keziban Unsal-Kacmaz; Anke Klippel; Stephan Grant; Alexei Brooun; Sergei Timofeevski
Journal:  Biosci Rep       Date:  2014-04-01       Impact factor: 3.840

5.  The interaction of p130Cas with PKN3 promotes malignant growth.

Authors:  Jakub Gemperle; Michal Dibus; Lenka Koudelková; Daniel Rosel; Jan Brábek
Journal:  Mol Oncol       Date:  2018-12-03       Impact factor: 6.603

Review 6.  The structure and function of protein kinase C-related kinases (PRKs).

Authors:  Georgios Sophocleous; Darerca Owen; Helen R Mott
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

7.  A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18.

Authors:  Michal Dibus; Jan Brábek; Daniel Rösel
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.